Tuesday 26 November 2019

Psilocybin for major depression granted Breakthrough Therapy by FDA

Psilocybin for major depression granted Breakthrough Therapy by FDA

The US Food and Drug Administration (FDA) has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD).

Continue reading...

No comments:

Post a Comment